Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 524

1.

The soluble form of LOTUS inhibits Nogo receptor type 1-mediated signaling induced by B lymphocyte stimulator and chondroitin sulfate proteoglycans.

Kawakami Y, Saito Y, Nakagawa R, Kurihara Y, Takei K.

Neurosci Lett. 2018 Jun 25;683:61-68. doi: 10.1016/j.neulet.2018.06.045. [Epub ahead of print]

PMID:
29953923
2.

Implication of Aortic Root Dilation and Stiffening in Patients with Tetralogy of Fallot.

Takei K, Murakami T, Takeda A.

Pediatr Cardiol. 2018 Jun 6. doi: 10.1007/s00246-018-1917-5. [Epub ahead of print]

PMID:
29876583
3.

Fingolimod-associated PML with mild IRIS in MS: A clinicopathologic study.

Nishiyama S, Misu T, Shishido-Hara Y, Nakamichi K, Saijo M, Takai Y, Takei K, Yamamoto N, Kuroda H, Saito R, Watanabe M, Tominaga T, Nakashima I, Fujihara K, Aoki M.

Neurol Neuroimmunol Neuroinflamm. 2017 Nov 10;5(1):e415. doi: 10.1212/NXI.0000000000000415. eCollection 2018 Jan.

4.

Molecular association model of PPARα and its new specific and efficient ligand, pemafibrate: Structural basis for SPPARMα.

Yamamoto Y, Takei K, Arulmozhiraja S, Sladek V, Matsuo N, Han SI, Matsuzaka T, Sekiya M, Tokiwa T, Shoji M, Shigeta Y, Nakagawa Y, Tokiwa H, Shimano H.

Biochem Biophys Res Commun. 2018 May 5;499(2):239-245. doi: 10.1016/j.bbrc.2018.03.135. Epub 2018 Mar 22.

PMID:
29567478
5.

Photoresponse of graphene field-effect-transistor with n-type Si depletion layer gate.

Kobayashi S, Anno Y, Takei K, Arie T, Akita S.

Sci Rep. 2018 Mar 19;8(1):4811. doi: 10.1038/s41598-018-22974-7.

6.

Taenia saginata Infection Diagnosed Based on the Number of Uterine Branches Observed During Capsule Endoscopy.

Hamada K, Takemoto K, Takei K, Yamasaki Y, Fujiwara Y.

Am J Gastroenterol. 2018 Mar;113(3):327. doi: 10.1038/ajg.2017.444. No abstract available.

PMID:
29535435
7.

Cerebrospinal fluid level of Nogo receptor 1 antagonist lateral olfactory tract usher substance (LOTUS) correlates inversely with the extent of neuroinflammation.

Takahashi K, Takeuchi H, Kurihara Y, Doi H, Kunii M, Tanaka K, Nakamura H, Fukai R, Tomita-Katsumoto A, Tada M, Higashiyama Y, Joki H, Koyano S, Takei K, Tanaka F.

J Neuroinflammation. 2018 Feb 17;15(1):46. doi: 10.1186/s12974-018-1084-x.

8.

A soft lithographic approach to fabricate InAs nanowire field-effect transistors.

Lee SH, Shin SH, Madsen M, Takei K, Nah J, Lee MH.

Sci Rep. 2018 Feb 16;8(1):3204. doi: 10.1038/s41598-018-21420-y.

9.

The soluble form of LOTUS inhibits Nogo receptor-mediated signaling by interfering with the interaction between Nogo receptor type 1 and p75 neurotrophin receptor.

Kawakami Y, Kurihara Y, Saito Y, Fujita Y, Yamashita T, Takei K.

J Neurosci. 2018 Feb 9. pii: 0953-17. doi: 10.1523/JNEUROSCI.0953-17.2018. [Epub ahead of print]

PMID:
29440387
10.

MicroRNA-196a-5p is a potential prognostic marker of delayed lymph node metastasis in early-stage tongue squamous cell carcinoma.

Maruyama T, Nishihara K, Umikawa M, Arasaki A, Nakasone T, Nimura F, Matayoshi A, Takei K, Nakachi S, Kariya KI, Yoshimi N.

Oncol Lett. 2018 Feb;15(2):2349-2363. doi: 10.3892/ol.2017.7562. Epub 2017 Dec 8.

11.

Serum selenium and selenoprotein-P levels in autoimmune thyroid diseases patients in a select center: a transversal study.

Federige MAF, Romaldini JH, Miklos ABPP, Koike MK, Takei K, Portes ES.

Arch Endocrinol Metab. 2017 Dec;61(6):600-607. doi: 10.1590/2359-3997000000309.

12.

Evolving affinity between Coulombic reversibility and hysteretic phase transformations in nano-structured silicon-based lithium-ion batteries.

Ogata K, Jeon S, Ko DS, Jung IS, Kim JH, Ito K, Kubo Y, Takei K, Saito S, Cho YH, Park H, Jang J, Kim HG, Kim JH, Kim YS, Choi W, Koh M, Uosaki K, Doo SG, Hwang Y, Han S.

Nat Commun. 2018 Feb 2;9(1):479. doi: 10.1038/s41467-018-02824-w.

13.

Dynamic clustering of dynamin-amphiphysin helices regulates membrane constriction and fission coupled with GTP hydrolysis.

Takeda T, Kozai T, Yang H, Ishikuro D, Seyama K, Kumagai Y, Abe T, Yamada H, Uchihashi T, Ando T, Takei K.

Elife. 2018 Jan 23;7. pii: e30246. doi: 10.7554/eLife.30246.

14.

Elevated serum levels of cardiovascular biomarkers are associated with progression of renal cancer.

Kamai T, Tokura Y, Uematsu T, Sakamoto K, Suzuki I, Takei K, Narimatsu T, Kambara T, Yuki H, Betsunoh H, Abe H, Fukabori Y, Yashi M, Yoshida KI.

Open Heart. 2018 Jan 3;5(1):e000666. doi: 10.1136/openhrt-2017-000666. eCollection 2018.

15.

An Acute Case of Granulomatous Amoebic Encephalitis-Balamuthia mandrillaris Infection.

Takei K, Toyoshima M, Nakamura M, Sato M, Shimizu H, Inoue C, Shimizu Y, Yagita K.

Intern Med. 2018 May 1;57(9):1313-1316. doi: 10.2169/internalmedicine.0011-17. Epub 2018 Jan 11.

16.

Significance of sarcopenia as a prognostic factor for metastatic urothelial carcinoma patients treated with systemic chemotherapy.

Abe H, Takei K, Uematsu T, Tokura Y, Suzuki I, Sakamoto K, Nishihara D, Yamaguchi Y, Mizuno T, Nukui A, Kobayashi M, Kamai T.

Int J Clin Oncol. 2018 Apr;23(2):338-346. doi: 10.1007/s10147-017-1207-x. Epub 2017 Nov 2.

PMID:
29098519
17.

A Japanese Case of Esophageal Lichen Planus that Was Successfully Treated with Systemic Corticosteroids.

Sato Y, Takenaka R, Matsumi A, Takei K, Okanoue S, Yasutomi E, Kawai D, Takemoto K, Tsugeno H, Miyake T, Fujiki S.

Intern Med. 2018 Jan 1;57(1):25-29. doi: 10.2169/internalmedicine.8668-16. Epub 2017 Oct 11.

18.

Regulation of axonal regeneration by the level of function of the endogenous Nogo receptor antagonist LOTUS.

Hirokawa T, Zou Y, Kurihara Y, Jiang Z, Sakakibara Y, Ito H, Funakoshi K, Kawahara N, Goshima Y, Strittmatter SM, Takei K.

Sci Rep. 2017 Sep 21;7(1):12119. doi: 10.1038/s41598-017-12449-6.

19.

LOTUS overexpression accelerates neuronal plasticity after focal brain ischemia in mice.

Takase H, Kurihara Y, Yokoyama TA, Kawahara N, Takei K.

PLoS One. 2017 Sep 7;12(9):e0184258. doi: 10.1371/journal.pone.0184258. eCollection 2017.

20.

Preoperative Pulmonary Function Tests Predict Aspiration Pneumonia After Gastric Endoscopic Submucosal Dissection.

Matsumi A, Takenaka R, Ando C, Sato Y, Takei K, Yasutomi E, Okanoue S, Oka S, Kawai D, Kataoka J, Takemoto K, Tsugeno H, Fujiki S, Kawahara Y.

Dig Dis Sci. 2017 Nov;62(11):3084-3090. doi: 10.1007/s10620-017-4750-4. Epub 2017 Sep 6.

PMID:
28879570
21.

Post-hoc analysis of open-label extension period of study MCI186-19 in amyotrophic lateral sclerosis.

Takei K, Tsuda K, Takahashi F, Palumbo J.

Amyotroph Lateral Scler Frontotemporal Degener. 2017 Oct;18(sup1):64-70. doi: 10.1080/21678421.2017.1365372.

PMID:
28872916
22.

Post-hoc analysis of MCI186-17, the extension study to MCI186-16, the confirmatory double-blind, parallel-group, placebo-controlled study of edaravone in amyotrophic lateral sclerosis.

Takahashi F, Takei K, Tsuda K, Palumbo J.

Amyotroph Lateral Scler Frontotemporal Degener. 2017 Oct;18(sup1):32-39. doi: 10.1080/21678421.2017.1361442.

PMID:
28872914
23.

Post-hoc analysis of randomised, placebo-controlled, double-blind study (MCI186-19) of edaravone (MCI-186) in amyotrophic lateral sclerosis.

Takei K, Takahashi F, Liu S, Tsuda K, Palumbo J.

Amyotroph Lateral Scler Frontotemporal Degener. 2017 Oct;18(sup1):49-54. doi: 10.1080/21678421.2017.1361443.

PMID:
28872913
24.

An assessment of treatment guidelines, clinical practices, demographics, and progression of disease among patients with amyotrophic lateral sclerosis in Japan, the United States, and Europe.

Takei K, Tsuda K, Takahashi F, Hirai M, Palumbo J.

Amyotroph Lateral Scler Frontotemporal Degener. 2017 Oct;18(sup1):88-97. doi: 10.1080/21678421.2017.1361445. Review.

PMID:
28872912
25.

Pharmacokinetic profile of edaravone: a comparison between Japanese and Caucasian populations.

Nakamaru Y, Kinoshita S, Kawaguchi A, Takei K, Palumbo J, Suzuki M.

Amyotroph Lateral Scler Frontotemporal Degener. 2017 Oct;18(sup1):80-87. doi: 10.1080/21678421.2017.1353100.

PMID:
28872908
26.

Edaravone and its clinical development for amyotrophic lateral sclerosis.

Takei K, Watanabe K, Yuki S, Akimoto M, Sakata T, Palumbo J.

Amyotroph Lateral Scler Frontotemporal Degener. 2017 Oct;18(sup1):5-10. doi: 10.1080/21678421.2017.1353101. Review.

PMID:
28872907
27.

Pfannenstiel laparoendoscopic reduced-port bilateral radical nephrectomy for a patient with renal cell carcinoma undergoing hemodialysis.

Nomura T, Yamasaki M, Takei K, Sato F, Terachi T, Mimata H.

Asian J Endosc Surg. 2018 May;11(2):177-181. doi: 10.1111/ases.12417. Epub 2017 Aug 30.

PMID:
28856871
28.

[Diagnostic Impact of 3D-CT with Retrograde Pyelography for Ureteropelvic Junction Obstruction : A Case Report].

Takei K, Abe H, Nishihara D, Mizuno T, Tokura Y, Suzuki I, Sakamoto K, Yuki H, Kambara T, Betsunou H, Yashi M, Fukabori Y, Kamai T, Inamura K, Shioyama Y, Kaji Y.

Hinyokika Kiyo. 2017 Jul;63(7):267-270. doi: 10.14989/ActaUrolJap_63_7_267. Japanese.

PMID:
28814706
29.

Wearable, Flexible, and Multifunctional Healthcare Device with an ISFET Chemical Sensor for Simultaneous Sweat pH and Skin Temperature Monitoring.

Nakata S, Arie T, Akita S, Takei K.

ACS Sens. 2017 Mar 24;2(3):443-448. doi: 10.1021/acssensors.7b00047. Epub 2017 Mar 13.

PMID:
28723207
30.

Efficient Skin Temperature Sensor and Stable Gel-Less Sticky ECG Sensor for a Wearable Flexible Healthcare Patch.

Yamamoto Y, Yamamoto D, Takada M, Naito H, Arie T, Akita S, Takei K.

Adv Healthc Mater. 2017 Sep;6(17). doi: 10.1002/adhm.201700495. Epub 2017 Jun 29.

PMID:
28661047
31.

Performance characteristics of prostate-specific antigen density and biopsy core details to predict oncological outcome in patients with intermediate to high-risk prostate cancer underwent robot-assisted radical prostatectomy.

Yashi M, Nukui A, Tokura Y, Takei K, Suzuki I, Sakamoto K, Yuki H, Kambara T, Betsunoh H, Abe H, Fukabori Y, Nakazato Y, Kaji Y, Kamai T.

BMC Urol. 2017 Jun 23;17(1):47. doi: 10.1186/s12894-017-0238-y.

32.

Laparoendoscopic single-site nephrectomy for hemodialysis patients with dialysis-related renal tumors.

Takei K, Yamasaki M, Abe S, Yamanaka N, Sejiyama S, Narimatsu T, Hata S, Shibuya T, Hirai K, Ando T, Shin T, Mori K, Sumino Y, Nomura T, Sato F, Terachi T, Mimata H.

Minim Invasive Ther Allied Technol. 2018 Jun;27(3):153-159. doi: 10.1080/13645706.2017.1335215. Epub 2017 Jun 12.

PMID:
28604288
33.

Direct measurement of optical trapping force gradient on polystyrene microspheres using a carbon nanotube mechanical resonator.

Yasuda M, Takei K, Arie T, Akita S.

Sci Rep. 2017 Jun 6;7(1):2825. doi: 10.1038/s41598-017-03068-2.

34.

Blockade of chondroitin sulfate proteoglycans-induced axonal growth inhibition by LOTUS.

Kurihara Y, Saito Y, Takei K.

Neuroscience. 2017 Jul 25;356:265-274. doi: 10.1016/j.neuroscience.2017.05.034. Epub 2017 May 30.

PMID:
28571719
35.

The Effects of Elbow Bracing on Medial Elbow Joint Space Gapping Associated With Repetitive Throwing in High School Baseball Players.

Hattori H, Akasaka K, Otsudo T, Takei K, Yamamoto M.

Orthop J Sports Med. 2017 Apr 18;5(4):2325967117702361. doi: 10.1177/2325967117702361. eCollection 2017 Apr.

36.

Effects of K-877, a novel selective PPARα modulator, on small intestine contribute to the amelioration of hyperlipidemia in low-density lipoprotein receptor knockout mice.

Takei K, Nakagawa Y, Wang Y, Han SI, Satoh A, Sekiya M, Matsuzaka T, Shimano H.

J Pharmacol Sci. 2017 Apr;133(4):214-222. doi: 10.1016/j.jphs.2017.02.003. Epub 2017 Feb 11.

37.

Extravasation of Urine Associated with Bilateral Complete Ureteral Duplication, Vesicoureteral Reflux and Benign Prostatic Hyperplasia.

Suzuki I, Kaga K, Takei K, Tokura Y, Sakamoto K, Nishihara D, Mizuno T, Yuki H, Betsunoh H, Abe H, Yashi M, Fukabori Y, Yamanishi T, Kamai T.

Urol Case Rep. 2017 Jan 28;11:47-49. doi: 10.1016/j.eucr.2016.12.011. eCollection 2017 Feb.

38.

Patient-reported postoperative pain, body image, and cosmetic satisfaction after transumbilical laparoendoscopic single-site adrenalectomy.

Nomura T, Takei K, Abe S, Fukuda Y, Yamanaka N, Sejiyama S, Yamasaki M, Shibuya T, Ando T, Mori KI, Sumino Y, Sato F, Mimata H.

Asian J Endosc Surg. 2017 Aug;10(3):289-294. doi: 10.1111/ases.12361. Epub 2017 Feb 1.

PMID:
28145058
39.

Printed multifunctional flexible device with an integrated motion sensor for health care monitoring.

Yamamoto Y, Harada S, Yamamoto D, Honda W, Arie T, Akita S, Takei K.

Sci Adv. 2016 Nov 23;2(11):e1601473. doi: 10.1126/sciadv.1601473. eCollection 2016 Nov.

40.

Inhibition of SGLT2 alleviates diabetic nephropathy by suppressing high glucose-induced oxidative stress in type 1 diabetic mice.

Hatanaka T, Ogawa D, Tachibana H, Eguchi J, Inoue T, Yamada H, Takei K, Makino H, Wada J.

Pharmacol Res Perspect. 2016 May 30;4(4):e00239. doi: 10.1002/prp2.239. eCollection 2016 Aug.

41.

Selective peroxisome proliferator-activated receptor-α modulator K-877 efficiently activates the peroxisome proliferator-activated receptor-α pathway and improves lipid metabolism in mice.

Takei K, Han SI, Murayama Y, Satoh A, Oikawa F, Ohno H, Osaki Y, Matsuzaka T, Sekiya M, Iwasaki H, Yatoh S, Yahagi N, Suzuki H, Yamada N, Nakagawa Y, Shimano H.

J Diabetes Investig. 2017 Jul;8(4):446-452. doi: 10.1111/jdi.12621. Epub 2017 Apr 25.

42.

Significance of right atrial tension for the development of complications in patients after atriopulmonary connection Fontan procedure: potential indicator for Fontan conversion.

Izumi G, Senzaki H, Takeda A, Yamazawa H, Takei K, Furukawa T, Inai K, Shinohara T, Nakanishi T.

Heart Vessels. 2017 Jul;32(7):850-855. doi: 10.1007/s00380-016-0941-8. Epub 2017 Jan 7.

PMID:
28064364
43.

Axonal branching in lateral olfactory tract is promoted by Nogo signaling.

Iketani M, Yokoyama T, Kurihara Y, Strittmatter SM, Goshima Y, Kawahara N, Takei K.

Sci Rep. 2016 Dec 21;6:39586. doi: 10.1038/srep39586.

44.

Frequency of malformed infants in a tertiary center in Hokkaido, Japan over a period of 10 years.

Hayasaka I, Cho K, Uzuki Y, Morioka K, Akimoto T, Ishikawa S, Takei K, Yamada T, Morikawa M, Yamada T, Ariga T, Minakami H.

J Obstet Gynaecol Res. 2017 Mar;43(3):505-510. doi: 10.1111/jog.13229. Epub 2016 Dec 17.

PMID:
27987336
45.

CREB3L3 controls fatty acid oxidation and ketogenesis in synergy with PPARα.

Nakagawa Y, Satoh A, Tezuka H, Han SI, Takei K, Iwasaki H, Yatoh S, Yahagi N, Suzuki H, Iwasaki Y, Sone H, Matsuzaka T, Yamada N, Shimano H.

Sci Rep. 2016 Dec 16;6:39182. doi: 10.1038/srep39182.

46.

Familial Influences on Mismatch Negativity and Its Association with Plasma Glutamate Level: A Magnetoencephalographic Study in Twins.

Nishimura Y, Kawakubo Y, Suga M, Hashimoto K, Takei Y, Takei K, Inoue H, Yumoto M, Takizawa R, Kasai K.

Mol Neuropsychiatry. 2016 Oct;2(3):161-172. Epub 2016 Sep 20.

47.

A Simple High-Performance Liquid Chromatography for Determining Lapatinib and Erlotinib in Human Plasma.

Ohgami M, Homma M, Suzuki Y, Naito K, Yamada M, Mitsuhashi S, Fujisawa F, Kojima H, Kaburagi T, Uchiumi K, Yamada Y, Bando H, Hara H, Takei K.

Ther Drug Monit. 2016 Dec;38(6):657-662.

PMID:
27851685
48.

Anomalous mitral and tricuspid arcade in a patient with stenotic double-orifice tricuspid valve.

Nitta M, Takigiku K, Yasukochi S, Takei K, Tazawa S, Utsumi M, Okamura T.

J Echocardiogr. 2016 Dec;14(4):173-175. Epub 2016 Jun 1. No abstract available.

PMID:
27251224
49.
50.

Dynamin2 GTPase contributes to invadopodia formation in invasive bladder cancer cells.

Zhang Y, Nolan M, Yamada H, Watanabe M, Nasu Y, Takei K, Takeda T.

Biochem Biophys Res Commun. 2016 Nov 18;480(3):409-414. doi: 10.1016/j.bbrc.2016.10.063. Epub 2016 Oct 19.

PMID:
27771248

Supplemental Content

Support Center